Document Detail

Synchronisation of ovarian follicular waves in the dromedary camel (Camelus dromedarius).
MedLine Citation:
PMID:  18835669     Owner:  NLM     Status:  MEDLINE    
This study was designed to compare the efficacy of various treatments intended to synchronise follicular wave cycles in dromedary camels by removing the existing follicle of unknown size and replacing it with a follicle capable of ovulating at a known time. Camels were randomly assigned to one of five groups and treated with either (1) 5mg oestradiol benzoate (i.m.) and 100mg progesterone (i.m.; E/P, n=15), (2) 20 icrog GnRH analogue, buserelin (i.m.; GnRH, n=15), (3) 20 microg buserelin (i.m.) on Day 0 (T=0) and 500 microg prostaglandin on Day T+7 (GnRH/PG n=15), (4) transvaginal ultrasound-guided follicle ablation of all follicles > or =0.5 cm (ABL, n=15) or (5) 5 ml saline (i.m; Controls n=15). All camels were subsequently injected with 20 microg buserelin 14 days after the first treatment was given. The ovarian response was monitored daily by transrectal ultrasonography and the intervals from treatment to follicular wave emergence and also the day on which the new dominant follicle reached 1.3 cm was recorded. Amongst the treatment groups the mean interval from treatment to new follicle wave emergence and treatment to time taken for the new dominant follicle to reach 1.3 cm in diameter was shortest in the ABL group (2.3+/-0.5 days and 8.8+/-1.1 days respectively, P=0.044) and longest in the E/P group (6.4+/-0.8 days and 12.2+/-1.0 days respectively, P<0.001) whereas the GnRH and GnRH/PG groups were intermediate (3.0+/-0.5 days and 11.1+/-0.8 days GnRH; and 4.5+/-0.5 days and 10.7+/-0.7 days GnRH/PG). A total of 11/15 camels in both the GnRH and GnRH/PG groups had dominant follicles between 1.3 and 1.9 cm 14 days post treatment, of which 21 of the 22 follicles ovulated after GnRH injection on T+14. The ABL, E/P and control groups however, showed greater variability in follicle size with less camels having dominant follicles between 1.3 and 1.9 cm than the GnRH and GnRH/PG groups and more in the > or =2.0 cm or follicle regressing groups, therefore fewer of these camels ovulated (ABL n=7; E/P n=9; Control n=6) after GnRH injection on Day T+14. In conclusion, two GnRH injections 14 days apart or two GnRH injections 14 days apart and PG on Day 7 after the first GnRH were the most effective methods to synchronise ovulation rate in dromedary camels at a fixed time interval of 14 days after treatment.
J A Skidmore; G P Adams; M Billah
Related Documents :
3173939 - Optimal use of postmenopausal hormone replacement.
1658699 - Endometrial histology and bleeding patterns after 8 years of continuous combined estrog...
20103449 - Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized p...
8844879 - Gonadotrophin hormone releasing hormone agonist in cases of severe paraphilia: a lifeti...
1899079 - Intranasal buserelin versus surgery in the treatment of uterine leiomyomata: long-term ...
10099769 - Endometrial balloon ablation under local analgesia and intravenous sedation.
21885299 - Rotator cuff tears treated with a modified deltoid flap repair technique.
8546649 - Repair of the perineal defect after radical vulvar surgery: direct closure versus skin ...
8532289 - Combined phacoemulsification, endoscopic ciliary process photocoagulation, and intraocu...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2008-08-28
Journal Detail:
Title:  Animal reproduction science     Volume:  114     ISSN:  1873-2232     ISO Abbreviation:  Anim. Reprod. Sci.     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-06-02     Completed Date:  2009-09-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7807205     Medline TA:  Anim Reprod Sci     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  249-55     Citation Subset:  IM    
The Camel Reproduction Centre, PO Box 79914, Dubai, United Arab Emirates.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Buserelin / administration & dosage,  pharmacology
Camels / physiology*
Cloprostenol / administration & dosage,  pharmacology
Estradiol / administration & dosage,  pharmacology
Fertility Agents, Female / administration & dosage,  pharmacology
Ovarian Follicle / drug effects*
Ovulation / drug effects,  physiology
Ovulation Induction / methods*
Progesterone / administration & dosage,  pharmacology
Reg. No./Substance:
0/Fertility Agents, Female; 40665-92-7/Cloprostenol; 50-28-2/Estradiol; 57-83-0/Progesterone; 57982-77-1/Buserelin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Emergence of extended-spectrum beta-lactamases in Pseudomonas aeruginosa: about 24 cases at Rouen Un...
Next Document:  Treatment with human chorionic gonadotropin (hCG) for ovulation induction is associated with an imme...